ELEVATED CSF LEVELS OF SUBSTANCE-P AND HIGH-INCIDENCE OF RAYNAUD PHENOMENON IN PATIENTS WITH FIBROMYALGIA - NEW FEATURES FOR DIAGNOSIS

被引:347
作者
VAEROY, H
HELLE, R
FORRE, O
KASS, E
TERENIUS, L
机构
[1] UNIV OSLO,ULLEVAL HOSP,DEPT NEUROL,OSLO 1,NORWAY
[2] UNIV UPPSALA,DEPT PHARMACOL,S-75105 UPPSALA,SWEDEN
关键词
D O I
10.1016/0304-3959(88)90019-X
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:21 / 26
页数:6
相关论文
共 17 条
[1]  
BENNETT RM, 1986, J RHEUMATOL, V13, P676
[2]   NEUROPEPTIDES IN HUMAN CEREBROSPINAL-FLUID [J].
BERRETTINI, WH ;
NURNBERGER, JI ;
GOLD, PW ;
CHRETIEN, M ;
CHROUSOS, GP ;
CHAN, JSD ;
GOLDIN, LR ;
GERSHON, ES .
LIFE SCIENCES, 1985, 37 (13) :1265-1270
[3]   IMMUNOFLUORESCENT DETECTION OF IGG AT THE DERMAL EPIDERMAL JUNCTION IN PATIENTS WITH APPARENT PRIMARY FIBROSITIS SYNDROME [J].
CARO, XJ .
ARTHRITIS AND RHEUMATISM, 1984, 27 (10) :1174-1179
[4]  
DINERMAN H, 1986, J RHEUMATOL, V13, P368
[5]   POST-OCCLUSIVE CUTANEOUS VASODILATATION MEDIATED BY SUBSTANCE-P [J].
LEMBECK, F ;
DONNERER, J .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1981, 316 (02) :165-171
[6]  
LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282
[7]   OPIOID CONTROL OF THE FUNCTION OF PRIMARY AFFERENT SUBSTANCE-P FIBERS [J].
LEMBECK, F ;
DONNERER, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 114 (03) :241-246
[8]   SLEEP-RELATED MYOCLONUS IN RHEUMATIC PAIN MODULATION DISORDER (FIBROSITIS SYNDROME) AND IN EXCESSIVE DAYTIME SOMNOLENCE [J].
MOLDOFSKY, H ;
TULLIS, C ;
LUE, FA ;
QUANCE, G ;
DAVIDSON, J .
PSYCHOSOMATIC MEDICINE, 1984, 46 (02) :145-151
[9]  
NATHAN PW, 1980, PAIN SOC, P311
[10]  
OEHME P, 1985, PHARMAZIE, V40, P568